BMS-986235
|
B650857-10mg
|
≥99% |
2253947-47-4 |
10mg
|
¥ 7800.9
|
期货,请咨询 |
阿拉丁 |
BMS-986235
|
B650857-100mg
|
≥99% |
2253947-47-4 |
100mg
|
¥ 36000.9
|
期货,请咨询 |
阿拉丁 |
BA-53038B
|
B650840-5mg
|
≥98% |
2306195-65-1 |
5mg
|
¥ 2400.9
|
期货,请咨询 |
阿拉丁 |
BA-53038B
|
B650840-50mg
|
≥98% |
2306195-65-1 |
50mg
|
¥ 11000.9
|
期货,请咨询 |
阿拉丁 |
BA-53038B
|
B650840-10mg
|
≥98% |
2306195-65-1 |
10mg
|
¥ 3800.9
|
期货,请咨询 |
阿拉丁 |
BA-53038B
|
B650840-100mg
|
≥98% |
2306195-65-1 |
100mg
|
¥ 15000.9
|
期货,请咨询 |
阿拉丁 |
Budiodarone tartrate
|
B650815-5mg
|
≥99% |
478941-93-4 |
5mg
|
¥ 5100.9
|
期货,请咨询 |
阿拉丁 |
Budiodarone tartrate
|
B650815-10mg
|
≥99% |
478941-93-4 |
10mg
|
¥ 8200.9
|
期货,请咨询 |
阿拉丁 |
BI 224436
|
B650814-5mg
|
≥99% |
1155419-89-8 |
5mg
|
¥ 3500.9
|
期货,请咨询 |
阿拉丁 |
BI 224436
|
B650814-50mg
|
≥99% |
1155419-89-8 |
50mg
|
¥ 15000.9
|
期货,请咨询 |
阿拉丁 |
BI 224436
|
B650814-2mg
|
≥99% |
1155419-89-8 |
2mg
|
¥ 2333.9
|
期货,请咨询 |
阿拉丁 |
BI 224436
|
B650814-10mg
|
≥99% |
1155419-89-8 |
10mg
|
¥ 5000.9
|
期货,请咨询 |
阿拉丁 |
BI 224436
|
B650814-100mg
|
≥99% |
1155419-89-8 |
100mg
|
¥ 21000.9
|
期货,请咨询 |
阿拉丁 |
BI-3663
|
B650789-5mg
|
≥99% |
2341740-84-7 |
5mg
|
¥ 9800.9
|
期货,请咨询 |
阿拉丁 |
BI-3663
|
B650789-1mg
|
≥99% |
2341740-84-7 |
1mg
|
¥ 5500.9
|
期货,请咨询 |
阿拉丁 |
BI-3663
|
B650789-10mg
|
≥99% |
2341740-84-7 |
10mg
|
¥ 15000.9
|
期货,请咨询 |
阿拉丁 |
(R)-BPO-27
|
B650766-5mg
|
≥99% |
1415390-47-4 |
5mg
|
¥ 3500.9
|
期货,请咨询 |
阿拉丁 |
(R)-BPO-27
|
B650766-50mg
|
≥99% |
1415390-47-4 |
50mg
|
¥ 15000.9
|
期货,请咨询 |
阿拉丁 |
(R)-BPO-27
|
B650766-1mg
|
≥99% |
1415390-47-4 |
1mg
|
¥ 1500.9
|
期货,请咨询 |
阿拉丁 |
(R)-BPO-27
|
B650766-10mg
|
≥99% |
1415390-47-4 |
10mg
|
¥ 5000.9
|
期货,请咨询 |
阿拉丁 |
(R)-BPO-27
|
B650766-100mg
|
≥99% |
1415390-47-4 |
100mg
|
¥ 21000.9
|
期货,请咨询 |
阿拉丁 |
Berotralstat dihydrochloride
|
B650745-5mg
|
≥98% |
1809010-52-3 |
5mg
|
¥ 12500.9
|
期货,请咨询 |
阿拉丁 |
Berotralstat dihydrochloride
|
B650745-1mg
|
≥98% |
1809010-52-3 |
1mg
|
¥ 4200.9
|
期货,请咨询 |
阿拉丁 |
Budesonide impurity C
|
B650733-5mg
|
|
1040085-99-1 |
5mg
|
¥ 2600.9
|
期货,请咨询 |
阿拉丁 |